1. After analyzing the Chinese version of Barron's Weekly, it is believed that Wan Tai's achievements in the capital market depend on strength for three points and luck for seven points. The obvious advantage of Wan Tai Bio is that it is the only company in China that has been vaccinated with HPV in the past two years.
2. On the one hand, the wealth comes from the large demand for detection reagents brought by the COVID-19 epidemic, and on the other hand, the whole society pays attention to the health brought by the epidemic. Looking into the future, these two factors that supported Wan Tai's biological performance and share price in the past two years will remain stable next year.
Brief introduction to Wan Tai's biology;
1, Beijing Wan Tai Biopharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines, which is affiliated to Yangshengtang Co., Ltd.
2. With the concept of "science-oriented, health-oriented", the purpose of "quality for survival, scientific and technological innovation for development" and the pursuit of "contributing to human health", the achievements of biotechnology will be transformed into high-quality products to serve the public.
3. On March 3rd, 2022, the State Administration of Pharmaceutical Products approved the listing of novel coronavirus (20 19-nCoV) antigen detection kit (colloidal gold method) of Beijing Wan Tai Biopharmaceutical Co., Ltd.
4. The company was established in 199 1 year. After 20 years of development and accumulation, it has developed from a small-scale laboratory at the beginning of its establishment to a modern diagnostic reagent production base with a building area of 20,000 square meters. With more than 450 employees, the company has become the largest AIDS diagnostic reagent production base in the Asia-Pacific region, the largest immunodiagnostic reagent in China and the national bio-high technology industrialization demonstration project base.